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        Recruitment of leukocytes into sites of infl  am-
mation is very effi   ciently regulated by the en-
dothelium. It provides a cascade of adhesion 
and signaling molecules, such as selectins, che-
mokines, and integrin ligands (  1  ), that attract 
and capture leukocytes, and it provides well 
controlled but not yet fully understood mecha-
nisms that open a path for leukocytes through 
the endothelial cell layer and the underlying 
basement membrane (  2, 3  ). 
  Although the molecular mechanisms medi-
ating the capture, activation, and migration of 
leukocytes are well characterized, the actual dia-
pedesis step, the migration of leukocytes through 
the blood vessel wall, is less well understood. 
There is good evidence that leukocytes can use 
two diff  erent pathways, either through the junc-
tions of neighboring endothelial cells or through 
the body of single endothelial cells (  4  ). The trans-
cellular pathway was documented in vivo (  5  ) as 
well as in vitro (  6, 7  ); however, quantitative com-
parison of both pathways showed that, at least 
in vitro, the junctional route seems to be the 
major pathway (  8  ), even though the importance 
of the transcellular pathway may vary depending 
on the vascular bed from which the endothelial 
cells originate (  7  ). 
  The majority of the endothelial membrane 
proteins that participate in leukocyte diapedesis 
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  We have shown recently that vascular endothelial protein tyrosine phosphatase (VE-PTP), an 
endothelial-specifi  c membrane protein, associates with vascular endothelial (VE)  –  cadherin 
and enhances VE-cadherin function in transfected cells (Nawroth, R., G. Poell, A. Ranft, 
U. Samulowitz, G. Fachinger, M. Golding, D.T. Shima, U. Deutsch, and D. Vestweber. 2002. 
  EMBO J.   21:4885  –  4895). We show that VE-PTP is indeed required for endothelial cell 
contact integrity, because down-regulation of its expression enhanced endothelial cell 
permeability, augmented leukocyte transmigration, and inhibited VE-cadherin  –  mediated 
adhesion. Binding of neutrophils as well as lymphocytes to endothelial cells triggered rapid 
(5 min) dissociation of VE-PTP from VE-cadherin. This dissociation was only seen with tumor 
necrosis factor       –  activated, but not resting, endothelial cells. Besides leukocytes, vascular 
endothelial growth factor also rapidly dissociated VE-PTP from VE-cadherin, indicative of a 
more general role of VE-PTP in the regulation of endothelial cell contacts. Dissociation of 
VE-PTP and VE-cadherin in endothelial cells was accompanied by tyrosine phoshorylation of 
VE-cadherin,     -catenin, and plakoglobin. Surprisingly, only plakoglobin but not     -catenin 
was necessary for VE-PTP to support VE-cadherin adhesion in endothelial cells. In addition, 
inhibiting the expression of VE-PTP preferentially increased tyrosine phosphorylation of 
plakoglobin but not     -catenin. In conclusion, leukocytes interacting with endothelial cells 
rapidly dissociate VE-PTP from VE-cadherin, weakening endothelial cell contacts via a 
mechanism that requires plakoglobin but not     -catenin. 
© 2008 Nottebaum et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the fi  rst six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons
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  In this paper, we show that VE-PTP is indeed essential for 
the maintenance of endothelial cell contact integrity and for 
the adhesive function of VE-cadherin in endothelial cells. 
Consequently, knocking down VE-PTP expression by RNA 
interference increased diapedesis of leukocytes. Furthermore, 
docking of leukocytes to endothelial cells triggered the disso-
ciation of VE-PTP from VE-cadherin within minutes, sug-
gesting a mechanism that allows leukocytes to reduce the 
adhesive function of VE-cadherin and, thereby, to support the 
opening of endothelial cell contacts. Interestingly, VEGF trig-
gers the dissociation of VE-PTP and VE-cadherin with similar 
kinetics. Searching for adherens junction proteins in endothe-
lial cells, which could mediate the eff  ect of VE-PTP on VE-
cadherin, we found that it is plakoglobin but not     -catenin 
that is required for VE-PTP to support VE-cadherin  –  medi-
ated adhesion. 
    RESULTS   
  Redistribution of VE-PTP to endothelial cell contacts 
and increased VE-cadherin association 
with higher cell density 
  Because we had shown previously that VE-PTP supports VE-
cadherin function when exogenously expressed in transfected 
cells (  40  ), we expected it to be expressed at endothelial cell 
contacts. Surprisingly, VE-PTP was hardly detectable at cell 
contacts of mouse bEnd.3 endothelioma cells when recently 
confl  uent cells were analyzed. Instead, VE-PTP was found at 
an intracellular compartment located close to the nucleus (  Fig. 
1 A  ).   Staining of this compartment for VE-PTP was gradually 
lost with increasing confl  uence, whereas cell contact staining 
increased (  Fig. 1 A  ). At 8 d after plating (cells had been plated 
at a 12.5-fold lower density than normal; see Materials and 
methods), VE-PTP was much less visible at intracellular sites 
and colocalized with VE-cadherin at cell contacts (  Fig. 1, 
A and B  ). Immunoprecipitates of VE-PTP contained consider-
ably more VE-cadherin when obtained from cells analyzed 8 d 
after plating compared with cells at 5 d after plating, although 
similar amounts of VE-PTP and VE-cadherin (standardized to 
the protein content of cell lysates) were expressed in both cell 
samples (  Fig. 2 A  ).   A similar result was obtained for human 
umbilical vein endothelial cells (HUVECs) plated at the same 
cell density but grown for 3, 4, and 5 d (  Fig. 2 B  ). Thus, with-
out aff  ecting overall cellular expression levels, increasing cell 
density is accompanied by increasing amounts of VE-PTP at 
cell contacts and more VE-PTP associated with VE-cadherin. 
  Association of VE-PTP and VE-cadherin could also be 
verifi  ed in vivo, as shown by coimmunoprecipitations from 
lysates of mouse lung homogenates (  Fig. 2 D  ). We could 
demonstrate that VE-PTP  –  VE-cadherin association occurs 
in intact cells and not just subsequently to the lysis procedure, 
because both proteins were coprecipitated from lysates of 
CHO cells that coexpressed the proteins but not from mixed 
lysates of two CHO cell lines, each expressing only one of 
the two proteins (  Fig. 2 C  ). 
  To characterize the intracellular compartment that accu-
mulates VE-PTP at low cell density, we allowed endothelial 
are found at endothelial cell contacts. Platelet endothelial cell 
adhesion molecule (PECAM-1) (  9  ), the small family of tight 
junction  –  associated junctional adhesion molecules (JAMs) 
(  10  ), the endothelial cell –  selective adhesion molecule (ESAM) 
(  11  ), CD99 (  12, 13  ), and CD99L2 (  14  ) are all required in 
vivo for the migration of leukocytes through the vessel wall, 
as was demonstrated either by blocking antibodies and/or by 
analyzing gene-defi  cient mice. Diapedesis was described as a 
process of sequential steps, with PECAM-1 being important 
for the entry of leukocytes into the contact area between en-
dothelial cells and CD99 being required for the movement 
through the endothelial cell layer, as suggested from in vitro 
transmigration experiments (  12, 15  ). In vivo, it was shown 
that mice defi  cient for PECAM-1 accumulate leukocytes be-
tween the endothelium and basement membrane, whereas 
leukocytes become trapped between endothelial contacts in 
JAM-A  –  defi  cient mice (  16  ). 
  In contrast, vascular endothelial (VE)  –  cadherin acts as a 
barrier in leukocyte diapedesis. It is of major importance for the 
stability of endothelial cell contacts (  17  –  19  ), and antibodies 
against VE-cadherin can disrupt endothelial junctions in vivo 
(  20  ) and can enhance leukocyte recruitment into infl  amed 
peritoneum (  21  ). Thus, it is reasonable to assume that homo-
philic VE-cadherin trans interactions need to be opened to al-
low leukocytes to migrate through the endothelial cell barrier. 
Indeed, it has been described that VE-cadherin moves away 
from endothelial cell contacts at sites of leukocyte diapedesis, 
whereas other adhesion molecules such as intercellular adhe-
sion molecule (ICAM) 1 and PECAM-1 form a ringlike struc-
ture surrounding leukocytes at such sites (  22  –  24  ). 
  Tyrosine phosphorylation of adherens junction proteins 
has been correlated with the loosening of cadherin-mediated 
adhesion in various cell types (  25  –  27  ). For endothelial cells, 
soluble factors that increase vascular permeability, such as his-
tamine, thrombin, and vascular endothelial growth factor 
(VEGF), as well as C5a-activated neutrophils, were shown to 
aff  ect tyrosine phosphorylation of various components of the 
VE-cadherin  –  catenin complex ( 28  –  31  ). In addition, the dock-
ing of leukocytes to endothelial cells was found to stimulate 
tyrosine phosphorylation of cortactin, which was demonstrated 
to be essential for transmigration (  32  –  34  ). Very recently, it 
was shown that the binding of leukocytes to ICAM-1 stimu-
lated tyrosine phosphorylation of VE-cadherin. Intriguingly, 
VE-cadherin mutant proteins defi   cient for certain tyrosine 
residues inhibited leukocyte diapedesis (  35, 36  ). 
  Vascular endothelial protein tyrosine phosphatase (VE-
PTP) is an endothelial-specifi  c membrane protein that can 
bind to the endothelial tyrosine kinase receptor Tie-2 (  37  ). 
VE-PTP is essential for vascular remodeling, and gene-dis-
rupted mice die at E9.5 during embryonic development (  38, 
39  ). We found that this tyrosine phosphatase associates spe-
cifi  cally with VE-cadherin and enhances the adhesive func-
tion of VE-cadherin when cotransfected in Chinese hamster 
ovary (CHO) cells (  40  ). Whether VE-PTP is indeed rele-
vant for the function of VE-cadherin in endothelial cells has 
not yet been analyzed. JEM VOL. 205, November 24, 2008 
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    Figure 1.         VE-PTP redistributes from an endosomal recycling compartment to endothelial cell contacts with increasing cell confl  uence.  
(A) Indirect immunofl  uorescence staining of mouse bEnd.3 endothelioma of increasing cell confl  uence (days after seeding are indicated) with an mAb 
against VE-PTP. VE-PTP was found in cell contacts with increasing cell confl  uence (arrowheads). (B) Fully confl  uent bEnd.3 cells were doublestained for 
VE-PTP (red) and VE-cadherin (green). Merged image is shown on the right. (C) Subconfl  uent bEnd.3 cells were allowed to endocytose Texas red  –  conju-
gated mouse transferrin for 30 min. Subsequently, fi  xed cells were stained for VE-PTP (green). The boxed cell is shown below at higher magnifi  cation. 
(D) Subconfl  uent bEnd.3 cells were doublestained for the recycling endosome marker Rab11 (red) and VE-PTP (green). Merged image is shown on the 
right. Visualization for all micrographs was done by confocal laser scanning microscopy. Each experiment is representative for three (A, B, and D) and 
two (C) independent experiments. Bars, 20   μ  m.     2932 VE-PTP IN LEUKOCYTE DIAPEDESIS   | Nottebaum et al. 
with negative control siRNA (  Fig. 3 A  ).   VE-PTP staining was 
undetectable in endothelioma cells after siRNA (not depicted). 
Silencing of VE-PTP did not cause loss of confl  uence of endo-
thelial cells, and immunofl  uorescence staining for VE-cadherin, 
JAM-A, ESAM, and PECAM-1 at cell contacts was essentially 
unchanged (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20080406/DC1). Using this technique, we 
tested whether inhibition of VE-PTP expression would aff  ect 
the permeability of a monolayer of mouse endothelioma cells 
for the diff  usion of 250 kD FITC-dextran. bEnd.5 cells trans-
fected with the VE-PTP  –  specifi  c siRNA or with a negative 
control siRNA were plated on Transwell fi  lters for 24 h before 
the assay. As shown in   Fig. 3 B  , inhibition of VE-PTP expres-
sion by siRNA increased the cell layer permeability by 60   ±   
15% as compared with the control. Thus, VE-PTP is required 
for the maintenance of cell contact integrity in endothelial cells. 
  To determine whether VE-PTP aff  ects endothelial cell 
contacts directly via acting on VE-cadherin, we tested whether 
cells to endocytose Texas red  –  labeled transferrin for 30 min 
and costained the cells with antibodies against VE-PTP. As 
shown in   Fig. 1 C  , a large fraction of the VE-PTP  –  contain-
ing vesicles colocalized with endocytic vesicles. Comparison 
with Rab11, a marker for the endocytic recycling compart-
ment, again showed a partial overlap with the staining for 
VE-PTP (  Fig. 1 D  ). Thus, VE-PTP seems to reside in an en-
docytic compartment until it is translocated to endothelial 
cell contacts once the junctions have matured. 
  VE-PTP is required for endothelial cell contact integrity 
and VE-cadherin function 
  To investigate the relevance of VE-PTP for endothelial cell 
contact integrity, we inhibited the expression of VE-PTP in 
endothelial cells by small interfering RNA (siRNA). As shown 
in immunoblots (  Fig. 3 A  ), with this technique we could inhibit 
the expression of VE-PTP in bEnd.5 mouse endothelioma cells 
by up to 95% and in HUVECs by up to 90% when compared 
    Figure 2.         VE-PTP association with VE-cadherin increases with endothelial cell confl  uence and association occurs in vivo.   bEnd.3 cells (A) and 
HUVECs (B) of increasing cell confl  uence (days after seeding are indicated above) were subjected to immunoprecipitations for VE-PTP (or human homologue 
hPTP    ), followed by immunoblotting for VE-cadherin and VE-PTP, as indicated on the right. Aliquots of cell lysates with identical protein content were immuno-
blotted directly for VE-cadherin (bottom). Molecular weight markers are indicated (left). Preimmune serum was used for negative controls. (C) CHO coex-
pressing VE-PTP and VE-cadherin (coexpression) or mixed lysates of CHO expressing either only VE-PTP or only VE-cadherin (mixed lysate) were subjected to 
immunoprecipitations for VE-PTP and subsequent immunoblotting, as described in A. (D) Lungs of mice were lysed and subjected to immunoprecipitation for 
VE-PTP and subsequent immunoblotting, as described in A. Each experiment is representative for three (A, B, and C) and fi  ve (D) independent experiments.    JEM VOL. 205, November 24, 2008 
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    Figure 3.         Knocking down VE-PTP expression in endothelial cells by siRNA decreases cell contact integrity and VE-cadherin  –  mediated 
adhesion and increases neutrophil transmigration.   (A) Mouse bEnd.5 endothelioma cells and HUVECs were transfected with control siRNAs (con-
trol) or with siRNAs directed against VE-PTP or hPTP-    , respectively. 24 h later, cell lysates were immunoblotted with pAbs against mouse VE-PTP that 
cross react with human hPTP-    . Equal loading was controlled by blotting for tubulin (bottom). Molecular weights are shown. (B) Paracellular perme-
ability for 250 kD FITC-dextran was determined for bEnd.5 cells, transfected either with control siRNAs or with siRNAs directed against VE-PTP and 
cultured on Transwell fi  lters. Permeability of control-transfected bEnd.5 cells was set to 100% (  n   = 6 for each group; control = 1.44   ×   10  5    ±   8.7   ×   10 3  
fl  uorescence units). (C) bEnd.5 cells were transfected with control siRNA or with siRNA directed against VE-PTP, and adhesion to immobilized VE-
cadherin  –  Fc and E-selectin  –  Fc was determined by counting adherent cells under a microscope (  n   = 6 for each group). Control binding to VE-cad-
herin  –  Fc was 188   ±   111 cells/area and was set as 100%. (D) Mouse neutrophils were allowed to transmigrate toward the chemokine KC through a 
monolayer of bEnd.5 cells on Transwell fi  lters transfected either with control siRNA or with siRNA directed against VE-PTP. The number of neutrophils 
migrated across control-transfected cells was set to 100% (  n   = 6 for each group; control = 3.6   ×   10  4    ±   5.5   ×   10 3   transmigrated cells). (E) Transmigra-
tion of human neutrophils through monolayers of HUVECs on coverslips that were either transfected with control siRNAs or with siRNAs directed 
against hPTP-     (left), or that were pretreated with a control antibody or an adhesion blocking mAb against human VE-cadherin (right;   n   =  8 – 10  for 
the various groups). In each case, the number of neutrophils migrating under negative control conditions was set to 100%. **, P   <   0.01; ***. P   <   0.001. 
Transmigrated cells per area were 23.8   ±   2.2 for control (left) and 17.2   ±   1.8 for control (right). Each experiment is representative of eight (B), fi  ve 
(C and D), and 3 (E) independent experiments. Analysis as in A was done for each siRNA experiment in the paper and was performed at least 40 times. 
Results are shown as means   ±   SEM.     2934 VE-PTP IN LEUKOCYTE DIAPEDESIS   | Nottebaum et al. 
cadherin upon 5 min of binding of T cells to the endothelium 
(  Fig. 4 B  ). Thus, neutrophils as well as lymphocytes reduce 
the association of VE-cadherin with VE-PTP within minutes. 
  Leukocyte-triggered dissociation of VE-PTP 
and VE-cadherin is only seen in TNF-      –  activated 
endothelial cells 
  We tested whether leukocyte-triggered dissociation of the 
VE-PTP  –  VE-cadherin complex would be detectable for rest-
ing as well as for TNF-      –  activated endothelial cells. To this 
end, either resting or 6-h TNF-      –  activated endothelial cells 
were incubated with mouse neutrophils for 5 min, and VE-
cadherin coprecipitation was probed as described above. Dis-
sociation of VE-PTP from VE-cadherin was only observed 
for activated endothelial cells but not for resting endothelium 
(  Fig. 4 A  ). Similar results were observed with lymphocytes 
(  Fig. 4 B  ). TNF-     was carefully removed from endothelial 
cells by washing the cells before adding the leukocytes. Our 
results show that leukocytes trigger the dissociation of VE-
PTP from VE-cadherin and, thereby, the weakening of VE-
cadherin function only in endothelial cells that are actively 
supporting adhesion. 
inhibiting the expression of VE-PTP in endothelial cells would 
aff  ect the binding of these cells to immobilized VE-cadherin  –
  Fc fusion protein. For negative controls we immobilized 
E-selectin  –  Fc. No specifi  c binding of endothelial cells to E-
selectin  –  Fc was observed, whereas strong binding was seen to 
VE-cadherin  –  Fc and this binding was reduced to background 
levels by siRNA for VE-PTP (  Fig. 3 C  ). 
  Because we know that VE-cadherin represents a barrier 
for extravasating neutrophils (  21  ), we tested whether the inhi-
bition of VE-PTP expression would enhance the migration of 
neutrophils across a monolayer of endothelial cells. At 24 h 
before the transmigration assay, endothelial cells were trans-
fected with VE-PTP or control siRNAs. Inhibition of VE-
PTP in mouse endothelioma cells increased transendothelial 
migration of mouse neutrophils by 44   ±   9% when compared 
with control transfected cells (  Fig. 3 D  ). Similar results were 
obtained for HUVECs. hPTP-     (the human homologue of 
VE-PTP) siRNA increased transmigration of human neutro-
phils by 60   ±   8% compared with negative control siRNA 
(  Fig. 3 E  ). This was quite a substantial increase, because an ad-
hesion-blocking mAb against human VE-cadherin, known to 
disrupt endothelial cell junctions, increased transmigration of 
neutrophils by 105   ±   19% (  Fig. 3 E  ). 
  Docking of neutrophils and lymphocytes to the surface 
of endothelial cells triggers the dissociation of VE-PTP 
from VE-cadherin 
  The results described above led us to conclude that VE-PTP 
supports the function of endothelial cells as a barrier for neu-
trophils, most likely by interacting with VE-cadherin and 
thereby enhancing its adhesive function. This raised the idea 
that neutrophils might interfere with the association of VE-
PTP with VE-cadherin to open endothelial cell contacts. We 
looked into this by testing whether the coprecipitation of 
VE-cadherin with anti  –  VE-PTP antibodies would be aff  ected 
by the binding of neutrophils to the surface of cultured mouse 
endothelioma cells. Neutrophils were allowed to bind to the 
monolayer of TNF-      –  activated endothelial cells for 5 min. 
Then the neutrophils were carefully and completely removed 
by washing the cells with PBS before lysing endothelial cells 
for immunoprecipitations, because we showed previously that 
VE-cadherin is easily degraded during experimentation by 
neutrophil proteases if neutrophils are not removed before 
analyzing the endothelial cells (  41  ). Endothelial cell lysates 
were subjected to immunoprecipitations for VE-PTP, and 
the amount of VE-cadherin coprecipitated with VE-PTP was 
analyzed in immunoblots. As shown in   Fig. 4 A  , the amount 
of coprecipiated VE-cadherin was reduced by 80% upon dock-
ing of neutrophils to the endothelium, whereas the amount 
of precipitated VE-PTP and the expression levels of VE-cad-
herin in the cell lysates were unaff  ected.   Of note, aliquots of 
cell lysates for subsequent VE-cadherin immunoblots were 
set aside and handled in the same way as the aliquots that 
were subjected to immunoprecipitations. Similar experiments 
were performed with ovalbumin-specifi  c antigen-stimulated 
T cells, resulting in a 75% reduction of coprecipitated VE-
    Figure 4.         Leukocytes binding to endothelial cells rapidly dissociate 
VE-cadherin from VE-PTP in a TNF-      –  dependent manner.   Mouse 
neutrophils (A) or antigen-stimulated ovalbumin-specifi  c mouse T cells 
(B) were added to 6-h TNF-      –  treated or untreated, highly confl  uent bEnd.5 
cells, and no leukocytes were added to negative control cells. After 5 min, 
leukocytes were removed by washing with PBS, and VE-PTP was immuno-
precipitated from endothelial cells and analyzed by immunoblotting for 
coprecipitated VE-cadherin or VE-PTP (as indicated on the right). To exclude 
proteolysis as a potential reason for the weakening of the VE-cadherin 
signal, aliquots of cell lysates were set aside and kept under identical con-
ditions as lysates subjected to immunoprecipitations before direct analysis 
by immunoblotting (bottom). Each experiment is representative of at least 
15 (A) and 3 (B) independent experiments. Molecular weights are shown.     JEM VOL. 205, November 24, 2008 
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not inhibit leukocyte-triggered dissociation of VE-cadherin 
and VE-PTP (not depicted). Furthermore,   “  conditioned  ”   
medium taken from endothelial cells that had been incu-
bated with neutrophils, when transferred to new endothelial 
cell layers, did not have any dissociation activity, arguing 
against a soluble factor that would trigger the eff  ect (not 
depicted). Thus, it is likely that endothelial receptors diff  er-
ent from the ones known to mediate adhesion of leuko-
cytes are required for leukocytes to dissociate VE-PTP from 
VE-cadherin. 
  Leukocytes stimulate catenin phosphorylation, 
and plakoglobin is a substrate for VE-PTP 
  We tested whether the binding of lymphocytes to TNF-      –
  activated mouse endothelioma cells would aff  ect tyrosine 
phosphorylation levels of the components of the VE-cad-
herin  –  catenin complex. TNF-     had been washed away 
before adding the lymphocytes. As shown in   Fig. 6 A  , we 
found that VE-cadherin as well as     -catenin and plakoglobin 
showed increased tyrosine phosphorylation levels upon lym-
phocyte incubation.   In agreement with a recent report (  36  ), 
tyrosine phosphorylation of     -catenin and plakoglobin were 
not enhanced if lymphocytes were incubated with resting en-
dothelial cells (not depicted). 
  None of the known endothelial adhesion receptors 
for leukocytes are required for leukocyte-triggered 
dissociation of the VE-PTP  –  VE-cadherin complex 
  To test whether any of the known endothelial adhesion re-
ceptors for leukocytes would be required for leukocytes to 
dissociate the VE-PTP  –  VE-cadherin complex, we analyzed 
endothelioma cells that had been established from mice defi  -
cient for both E- and P-selectin, for both ICAM-1 and -2, or 
for PECAM-1. We found that neutrophils or lymphocytes 
still triggered dissociation of the complex despite the lack of 
these adhesion molecules (  Fig. 5 A  ).   Similarly, leukocyte-trig-
gered dissociation of VE-PTP from VE-cadherin was also ob-
served with endothelial cells defi  cient for only ICAM-1 or 
only ICAM-2 (not depicted). In addition, antibodies against 
CD99 that block neutrophil and lymphocyte extravasation 
in vivo and transendothelial migration of leukocytes in vitro 
(  13, 14  ) were unable to inhibit the leukocyte-induced disso-
ciation of the VE-PTP  –  VE-cadherin complex (  Fig. 5 B  ). Thus, 
either diff  erent endothelial cell  –  surface receptors are involved 
in this process, or soluble mediators released by leukocytes 
may trigger the complex dissociation. Oxygen radicals poten-
tially released by neutrophils could be excluded as relevant 
in this assay because incubating neutrophils with endothelial 
cells in the presence of superoxide dismutase and catalase did 
    Figure 5.         Neither E- and P-selectin, ICAM-1 and -2, or PECAM-1 nor CD99 are required for leukocyte-triggered dissociation of the VE-PTP  –
  VE-cadherin complex.   (A) Highly confl  uent mouse endothelioma cells either double defi  cient for ICAM-1 and -2, or E- and P-selectin, or defi  cient for 
PECAM-1 (as indicated above) were treated for 6 h with TNF-     before adding either T cells (left two panels) or neutrophils (right two panels). After 5 min, 
leukocytes were removed, and VE-PTP immunoprecipitates and cell lysates were analyzed by immunoblotting for VE-cadherin and VE-PTP or for VE-cad-
herin, respectively, as described in   Fig. 4  . (B) TNF-    – treated  highly  confl  uent bEnd.5 cells were treated for 30 min either without antibody (   ),  preimmune 
antibodies (preserum), or anti-CD99 antibodies (CD99) before the addition of T lymphocytes for 10 min. Lymphocytes were removed, and VE-PTP precipi-
tates and cell lysates were analyzed as described in A. Each experiment is representative of three independent experiments. Molecular weights are shown.     2936 VE-PTP IN LEUKOCYTE DIAPEDESIS   | Nottebaum et al. 
oglobin by 40% when compared with the control siRNA 
treatment, whereas no eff  ect was seen for VE-cadherin and 
    -catenin. Similar results were obtained with HUVECs, ex-
cept that the increase in plakoglobin tyrosine phosphorylation 
was even stronger (80%) and a very slight increase in the 
  To test whether VE-PTP could aff  ect the tyrosine phos-
phorylation levels of components of the VE-cadherin  –  catenin 
complexes, we knocked down the expression of VE-PTP by 
siRNA in mouse endothelioma cells. As shown in   Fig. 6 B  , 
this treatment enhanced the tyrosine phosphorylation of plak-
    Figure 6.         Leukocytes trigger tyrosine phosphorylation of the VE-cadherin  –  catenin complex, and plakoglobin serves as substrate for VE-PTP.   
(A) Antigen-stimulated mouse T lymphocytes were allowed to adhere for the indicated times to highly confl  uent TNF-      –  activated bEnd.5 cells. After removal 
of T cells by washing with PBS, VE-cadherin was immunoprecipitated, and isolated VE-cadherin  –  catenin complexes were analyzed by immunoblotting with 
antiphosphotyrosine antibodies (pTyr) and antibodies against VE-cadherin,     -catenin, and plakoglobin (as indicated). (B) bEnd.5 cells were either transfected 
with control siRNAs or with siRNAs directed against VE-PTP. 24 h later, VE-cadherin was immunoprecipitated, and immunocomplexes (top two panels) and cell 
lysates (bottom two panels) were analyzed by immunoblotting with antibodies against phosphotyrosine (pTyr), plakoglobin, VE-cadherin, VE-PTP, and tubulin 
(as indicated). (C) HUVECs, instead of bEnd.5 cells, were analyzed as in B. (D) Mouse L929 fi  broblasts, pretreated with 1 mM pervanadate for 30 min and 10   μ  M 
of proteasome inhibitor for 2  –  3 h (to increase plakoglobin expression), were subjected to substrate trapping pull downs with GST (GST only), GST  –  VE-PTP WT, 
or GST  –  VE-PTP C/S D/A, followed by immunoblotting for plakoglobin and GST, as indicated on the right. The black line indicates that intervening lanes have 
been spliced out. Each experiment is representative for fi  ve (A and B), three (C), and two (D) independent experiments. Molecular weights are shown.    JEM VOL. 205, November 24, 2008 
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of VE-PTP on VE-cadherin function. To this end, we estab-
lished mouse endothelioma cells from gene-targeted mice 
lacking either plakoglobin or    -catenin. These cells expressed 
endothelial-specifi   c markers such as Tie-2, VEGFR-2, 
PECAM-1, and VE-cadherin (not depicted). With these cells, 
we tested whether down-regulation of the expression of VE-
PTP by siRNA would still aff  ect cell binding to immobilized 
VE-cadherin  –  Fc. Surprisingly, we found that reduction of 
VE-PTP expression in     -catenin  –  defi  cient endothelioma cells 
had a similar inhibitory eff  ect on VE-cadherin  –  mediated ad-
hesion as in normal endothelioma cells expressing all catenins 
(  Fig. 8 A  ).   In contrast, a strongly reduced inhibitory eff  ect was 
phosphorylation of VE-cadherin and     -catenin was seen (  Fig. 
6 C  ). Thus, plakoglobin is the major component of the VE-
cadherin  –  catenin complex whose tyrosine phosphorylation 
level can be aff  ected by the lack of VE-PTP, even in the ab-
sence of exogenous stimuli such as leukocytes, that could ac-
tively trigger tyrosine phosphorylation by activating kinases. 
  We tested whether plakoglobin is indeed a direct substrate 
for VE-PTP in glutathione S-transferase (GST) pull-down 
experiments using a VE-PTP   “  substrate-trapping  ”   mutant 
carrying the two point mutations C/S and D/A. Tyrosine 
phosphatase domains carrying these mutations in their active 
center lack catalytic activity but have preserved substrate bind-
ing activity (  42  ). Indeed, we were able to pull down plakoglo-
bin from lysates of L929 mouse fi  broblasts, whereas no signal 
was detected with the WT form of VE-PTP or with GST 
alone (  Fig. 6 D  ). L929 cells do not express cadherins, exclud-
ing the possibility that plakoglobin was possibly pulled down 
indirectly in the context of a cadherin  –  catenin complex. 
  VE-PTP  –  mediated support of VE-cadherin function requires 
plakoglobin but not     -catenin 
  To investigate which molecular entities of the VE-cadherin  –
  catenin complex are required for VE-PTP to enhance VE-
cadherin function, we generated three different types of 
triple-transfected CHO cell clones that stably expressed VE-
PTP under a mifepristone-inducible promoter, and a mutant of 
VE-cadherin together with VEGFR-2 under constitutive pro-
moters. VEGFR-2 was required for tyrosine phosphorylation 
of VE-cadherin (  39  ). The three diff  erent mutant proteins com-
prised a form of VE-cadherin in which all eight tyrosine resi-
dues within the cytoplasmic tail were replaced by phenylalanines 
(VE-YallF) and two truncated forms of VE-cadherin lacking 
either the last 83 (VE-    83) or the last 42 (VE-    42) amino acids 
of the intracellular domain, thus deleting the     -catenin/plako-
globin binding site. As read out for VE-cadherin function, we 
analyzed cell aggregation of the transfected CHO cells. We 
have shown previously that induction of VE-PTP in such tri-
ple-transfected CHO cells leads to a decrease of cell monolayer 
permeability if WT VE-cadherin is coexpressed (  40  ). In agree-
ment with this, we found now that induction of VE-PTP 
clearly increased cell aggregation of cells that expressed the WT 
form of VE-cadherin (  Fig. 7 A  ).   Interestingly, a similar eff  ect 
was seen in cells that expressed the VE-YallF mutant (  Fig. 7 A  ), 
demonstrating that the tyrosine residues in VE-cadherin are 
not essential for the eff  ect of VE-PTP on VE-cadherin. CHO 
cells expressing truncated VE-cadherin aggregated with lower 
effi   ciency, but were still able to aggregate in a VE-cadherin  –
  dependent manner when compared with nontransfected cells 
(  Fig. 7 B  ). However, the enhancing eff  ect of VE-PTP was lost 
in CHO cells that expressed the VE-    42 or the VE-    83 trun-
cation mutants (  Fig. 7 B  ). This suggests that VE-cadherin 
anchoring to the catenins is required for VE-PTP  –  mediated 
enhancement of VE-cadherin  –  adhesive function. 
  This requirement for the catenin-binding domain of VE-
cadherin prompted us to test whether plakoglobin and/or     -
catenin would be necessary in endothelial cells for the infl  uence 
    Figure 7.         VE-cadherin  –  catenin anchoring but no VE-cadherin 
tyrosine residues are required for VE-PTP support of adhesion in 
transfected CHO cells.   (A) Untransfected CHO cells (   );  triple-trans-
fected CHO cells stably expressing WT  –  VE-cadherin, VEGFR-2, and induc-
ible VE-PTP (WT); and CHO cells stably transfected with VE-cadherin YallF 
mutant (all tyrosines mutated to phenylalanines), VEGFR-2, and inducible 
VE-PTP (YallF) were stimulated for 10 h with mifepristone to induce VE-
PTP expression (+) or left unstimulated (    ). Subsequently, harvested cells 
were allowed to aggregate, and the number of cell aggregates was deter-
mined in a cell counter (  n   = 3 for each group). (B) In addition to untrans-
fected and triple-transfected WT controls (as in A), triple-transfected CHO 
cells expressing, in addition to VEGFR-2 and inducible VE-PTP, either the 
VE-cadherin     42 mutant (lacking the C-terminal 42 amino acids) or the 
VE-cadherin     83 mutant (lacking the C-terminal 83 amino acids) were 
analyzed in cell aggregation assays under mifepristone-induced (+) and 
noninduced (    ) conditions (  n   = 3 for each group). *, P   <   0.05; **, P   <   0.01; 
***, P   <   0.001. Each experiment is representative of four (A) and two (B) 
independent experiments. Results are shown as means   ±   SEM.     2938 VE-PTP IN LEUKOCYTE DIAPEDESIS   | Nottebaum et al. 
catenins would be aff  ected by VE-PTP. We compared anti  –
  VE-cadherin immunoprecipitates from triple-transfected (VE-
cadherin  –   and VEGFR-2  –  expressing) CHO cells that were or 
were not induced for VE-PTP expression by mifepristone. 
We found that the amount of plakoglobin coprecipiated with 
VE-cadherin was clearly increased upon induction of VE-PTP, 
whereas the amount of     -catenin was unchanged (  Fig. 9  ).   
Similar results were obtained with triple-transfected CHO cells 
that expressed VE-YallF instead of WT VE-cadherin (  Fig. 9  ). 
We conclude that VE-PTP stimulates the association of VE-
cadherin and plakoglobin and that this eff  ect is independent 
of tyrosine phosphorylation levels of VE-cadherin. 
  VEGF stimulates dissociation of the VE-cadherin  –  VE-PTP 
complex 
  VEGF has been reported to stimulate tyrosine phosphoryla-
tion of the VE-cadherin  –  catenin complex and endothelial cell 
layer permeability in HUVECs (  28  ). We could confi  rm this 
for bEnd.5 mouse endothelioma cells (  Fig. 10 B  ).   Interest-
ingly, phosphorylation of plakoglobin was clearly much more 
strongly induced than phosphorylation of     -catenin and VE-
cadherin (  Fig. 10 B  ). Of note, in contrast to previous reports, 
the cells were neither starved in serum-free medium nor pre-
treated with vanadate or even peroxyvanadate before VEGF 
treatment and analysis. Thus, we used the same conditions as 
when incubating the endothelial cells with leukocytes. Simi-
lar results were obtained with HUVECs (not depicted). Our 
results prompted us to test whether VEGF would interfere 
with the complex between VE-cadherin and VE-PTP. In-
deed, we found that VEGF treatment induced dissociation of 
the complex within minutes (  Fig. 10 A  ), in agreement with 
the kinetics of tyrosine phosphorylation of the VE-cadherin  –
  catenin complex. Because plakoglobin is necessary for VE-PTP 
to support cell adhesion, we tested whether it is required for 
leukocyte- or VEGF-triggered disassociation of VE-cadherin. 
Using plakoglobin-null endothelioma cells, we found that 
leukocytes as well as VEGF could still dissociate the VE-PTP  –
  VE-cadherin complex (  Fig. 10 C  ), suggesting that plakoglo-
bin is indeed aff  ected by the dissociation of VE-PTP from 
VE-cadherin rather than it eff  ecting the dissociation of this 
complex itself. 
    DISCUSSION   
  In this study, we report a novel mechanism for the control of 
endothelial cell contacts during leukocyte extravasation. We 
show that VE-PTP is an important component of the VE-
cadherin  –  catenin complex, which is required for the mainte-
nance of the endothelial barrier function. Leukocytes rapidly 
dissociate VE-PTP from this complex, suggesting that this re-
ceptor-type phosphatase represents a switch that leukocytes 
can use to open endothelial cell contacts. In addition, VE-PTP 
may be more generally relevant for the regulation of endothe-
lial cell contacts because the vascular permeability  –  inducing 
growth factor VEGF is also able to dissociate the phosphatase 
from VE-cadherin. Importantly, plakoglobin is an essential 
component of the cadherin complex, which is necessary for 
seen in plakoglobin-defi  cient cells (  Fig. 8 A  ). Thus, plakoglo-
bin but, surprisingly, not     -catenin is required for VE-PTP to 
enhance VE-cadherin function. Similarly, plakoglobin was also 
required for the eff  ect of VE-PTP on endothelial cell permea-
bility, because silencing of VE-PTP increased permeability 
less dramatically in endothelial cells defi  cient for plakoglobin 
than in cells expressing plakoglobin (  Fig. 8 B  ). 
  VE-PTP affects the association of VE-cadherin 
with plakoglobin 
  To fi  nd out how VE-PTP supports VE-cadherin function, 
we tested whether the anchoring of VE-cadherin with the 
    Figure 8.         VE-PTP supports VE-cadherin function via plakoglobin, 
but not     -catenin, and affects endothelial cell permeability via 
plakoglobin.   (A) WT mouse endothelioma cells and endothelioma cells 
lacking plakoglobin (plakoglobin     /    ) or    -catenin  (  -catenin    /   )  were 
transfected either with control siRNAs or with siRNAs directed against VE-
PTP and were allowed to adhere to immobilized VE-cadherin  –  Fc. Absolute 
numbers of controls in cells per area were 577   ±   256 (WT), 1,186   ±   138 
(plakoglobin     /    ), and 862   ±   179 (   -catenin    /    ). (B) Paracellular permeabil-
ity for 250 kD FITC-dextran was determined for mouse endothelioma cells, 
transfected as described in A and cultured on Transwell fi  lters. Absolute 
numbers of fl  uorescence units for controls were 2.43   ×   10  4    ±   1.16   ×   10 3  
(WT) and 4.17   ×   10  4    ±   2.65   ×   10 3   (plakoglobin    /    ). Adhesion and perme-
ability, respectively, of control-transfected cells were set to 100% (  n   = 6 for 
each group). **, P   <   0.01; ***, P   <   0.001. Each experiment is representative 
for three independent experiments. Results are shown as means   ±   SEM.     JEM VOL. 205, November 24, 2008 
ARTICLE
2939
gests that VE-PTP either aff  ects plakoglobin directly as a sub-
strate or aff  ects factors that indirectly infl  uence plakoglobin. 
Our results indeed suggest that plakoglobin is a substrate of 
VE-PTP, because a substrate-trapping mutant of VE-PTP binds 
to plakoglobin in cadherin-free L929 cell lysates and silencing 
of VE-PTP in endothelial cells predominantly aff  ects the ty-
rosine phosphorylation of plakoglobin. 
  The selective plakoglobin dependence of the VE-PTP in-
fl  uence on VE-cadherin function is remarkable for two rea-
sons. First, in contrast to the numerous reports on the relevance 
of     -catenin for the regulation of cadherin adhesiveness (  45  ), 
our results establish a mechanism that regulates VE-cadherin 
function selectively via plakoglobin. Very few papers have yet 
analyzed the impact of the phosphorylation of plakoglobin on 
the association with a cadherin (  48  ). Second, several years ago 
it was reported that plakoglobin is absent from recently con-
fl  uent endothelial cell contacts. The synthesis of plakoglobin is 
up-regulated and becomes assembled with VE-cadherin in 
junctional complexes only when the cells have reached high 
confl  uence after several days of culture (  49  ). It is intriguing, 
that similar to plakoglobin, VE-PTP is also located at endo-
thelial cell contacts only days after cells have reached confl  u-
ence. At the same time, VE-PTP is lost from an intracellular 
location that is at least in part overlapping with the endocytic 
compartment (  Fig. 1  ). Thus, maturation of endothelial junctions 
VE-PTP to support cell adhesion, whereas neither the tyro-
sine residues of the intracellular domain of VE-cadherin nor 
    -catenin are required for this eff  ect of VE-PTP. 
  Regulation of cadherin adhesive function has been attrib-
uted to tyrosine phosphorylation of adherens junction pro-
teins in various cell types (  26, 43, 44  ). Of these proteins, 
    -catenin and p120 are among the best characterized (  45, 46  ). 
Several papers describe the dissociation of     -catenin from the 
respective cadherin as a central step in regulating adhesion. 
For the vascular system, numerous lines of evidence have 
demonstrated that tyrosine phosphorylation of adherens junc-
tion proteins, especially     -catenin, correlate with the dissoci-
ation of endothelial cell contacts. Tyrosine phosphatases that 
were found to aff  ect the stability of endothelial junctions are 
the     -catenin  –  associated SHP-2 (  30  ), and the receptor-type 
RPTP-     that directly associates with the cytoplasmic tail of 
VE-cadherin (  47  ). However, none of them has yet been stud-
ied in the context of leukocyte transmigration. 
  With VE-PTP, we have found the fi  rst tyrosine phospha-
tase that is relevant for the control of endothelial cell contacts 
during leukocyte transmigration. In addition, we demonstrate 
that it is plakoglobin that is required for VE-PTP to stimulate 
VE-cadherin function in endothelial cells, whereas     -catenin 
is dispensable (  Fig. 8  ). This selectivity for only one of the two 
catenins that connect VE-cadherin with     -catenin clearly sug-
    Figure 9.         Induction of VE-PTP expression in CHO cells leads to increased association of plakoglobin with VE-cadherin.   CHO cells triple-trans-
fected with WT  –  VE-cadherin, VEGFR-2, and inducible VE-PTP (WT), and CHO cells stably transfected with VE-cadherin YallF mutant (all tyrosines mutated 
to phenylalanines), VEGFR-2, and inducible VE-PTP (YallF) were either induced for VE-PTP expression (+) or not induced (    ). Subsequently, VE-cadherin 
was immunoprecipitated, and immunocomplexes (top four panels) and cell lysates (bottom two panels) were analyzed in immunoblots for the indicated 
antigens. This experiment is representative of four independent experiments. Molecular weights are shown.     2940 VE-PTP IN LEUKOCYTE DIAPEDESIS   | Nottebaum et al. 
selectively enhanced the association between plakoglobin and 
VE-cadherin, whereas no eff  ect was seen for     -catenin. This 
could suggest that VE-PTP might stabilize the association of 
plakoglobin with VE-cadherin. However, we were not able 
to detect in endothelial cells that the dissociation of VE-PTP 
from VE-cadherin, triggered by leukocytes, would lead to 
the dissociation of plakoglobin from VE-cadherin (indirectly 
implicated in the results of   Fig. 6 A  ). Although this discrep-
ancy cannot yet be fully explained, we have to consider that 
much less VE-PTP than VE-cadherin is expressed in endothelial 
is accompanied by the redistribution of VE-PTP from an en-
dosome-like compartment to cell contacts and by increased 
association of plakoglobin and VE-PTP with VE-cadherin. 
We suggest that VE-PTP and plakoglobin are both required 
for the stabilization of endothelial cell contacts, and VE-PTP 
exerts this function through plakoglobin. 
  Despite the selective dependence on plakoglobin, we do 
not yet precisely know how VE-PTP supports cell contact 
integrity. It is interesting that the induction of VE-PTP in 
CHO cells cotransfected with VE-cadherin and VEGFR-2 
    Figure 10.         Stimulation of endothelial cells with VEGF dissociates VE-cadherin from VE-PTP and triggers tyrosine phosphorylation of the VE-
cadherin  –  catenin complex.   (A) bEnd.5 cells were stimulated with VEGF for the indicated time periods. Subsequently, VE-PTP was immunoprecipitated, 
and immunocomplexes (top two panels) and cell lysates (bottom panel) were analyzed in immunoblots for VE-cadherin and VE-PTP. (B) After stimulating 
bEnd.5 cells with VEGF for the indicated time periods, VE-cadherin was immunoprecipitated, and immunocomplexes were analyzed in immunoblots for 
tyrosine phosphorylation (pTyr), VE-cadherin,    -catenin,     -catenin, and plakoglobin (as indicated). (C) T cells (left) or VEGF (right) were added (+) or not 
(    ) to plakoglobin-null endothelioma cells for 10 min (T cells) or 20 min (VEGF). Subsequently, VE-PTP was immunoprecipitated, and immunocomplexes 
(top two panels) and cell lysates (bottom panel) were analyzed in immunoblots for VE-cadherin and VE-PTP (as indicated on the right). Each experiment is 
representative for seven (A), four (B), and two (C) independent experiments. Molecular weights are shown.     JEM VOL. 205, November 24, 2008 
ARTICLE
2941
endothelial cell contact stability seem to converge on the sta-
bility of the same complex. The attractive possibility, how-
ever, that VEGF itself might be mediating the leukocyte 
eff  ect as secreted mediator could be excluded, because block-
ing anti-VEGF antibodies did not inhibit the complex-disso-
ciating activity of leukocytes (unpublished data). 
  ICAM-1 cross-linking on resting endothelial cells only in-
creases tyrosine phosphorylation of VE-cadherin, but not of 
the catenins (  36  ). We could confi  rm this for the binding of 
lymphocytes to resting endothelium (unpublished data). In 
contrast, binding of lymphocytes to TNF-      –  activated endo-
thelial cells clearly increased tyrosine phosphorylation of VE-
cadherin,    -catenin, and plakoglobin. Thus, leukocyte-induced 
tyrosine phosphorylation of catenins and dissociation of VE-
PTP from VE-cadherin both require preactivation of the en-
dothelium with TNF-    . This further supports the concept 
that the dissociation of VE-PTP from the VE-cadherin com-
plex indeed participates in leukocyte-induced tyrosine phos-
phorylation of catenins. In addition, the fact that leukocytes 
cannot dissociate VE-PTP from VE-cadherin in resting cells 
suggests that VE-PTP may provide a mechanism that main-
tains endothelial cell contact integrity in nonactivated endo-
thelial cells that are not actively supporting transmigation. 
Only in the presence of infl  ammatory stimuli are leukocytes 
able to operate this   “  switch  ”   and destabilize endothelial con-
tacts via dissociation of VE-PTP from VE-cadherin. Whether 
this switch would be operational without the requirement of 
TNF activation in high endothelial cells specialized for effi   -
cient lymphocyte entry into lymph nodes will be an interest-
ing question to study. 
  In conclusion, our results establish VE-PTP as a new 
membrane protein at endothelial junctions that is involved in 
the regulation of endothelial cell contacts during leukocyte 
transmigration. Because VE-PTP is the fi  rst known endothe-
lial-specifi  c tyrosine phosphatase and because it is a receptor-
type protein with a large extracellular domain accessible from 
within the vasculature, VE-PTP represents a very interesting 
novel pharmacological target for the treatment of infl  amma-
tory diseases. 
  MATERIALS AND METHODS 
  Reagents and antibodies.     Transferrin  –  Texas red (Rockland), soybean tryp-
sin inhibitor (Sigma-Aldrich), DNase (Roche), laminin (Sigma-Aldrich), re-
combinant human TNF-     (PeproTech), gelatin (Sigma-Aldrich), fl  uorescent 
mounting medium (Dako), 250 kD FITC-dextran (Sigma-Aldrich), VEGF165 
(PeproTech), and proteasome inhibitor MG 132 (EMD) were all used. 
  The following antibodies were used: mAb 109.1 against VE-PTP (  38  ); 
pAb VE  –  PTP-C against VE-PTP (cross-reactive to the human homologue 
hPTP-    ) (  40  ); mAb 11D4.1 against mouse VE-cadherin and pAb C5 against 
mouse VE-cadherin (  21  ); pAb against mouse CD99 (  13  ) and mAb 1G8 
against ESAM (  50  ); pAb against human ESAM; mAb against PECAM-1 
1G5.1 and 5D2.6 (  11  ); pAb against JAM-A (  51  ), mAb cadherin-5 against 
human VE-cadherin, mAb against     -catenin, mAb against plakoglobin, and 
mAb against     -catenin (BD Biosciences); pAb C-19 against human VE-
cadherin and pAb Z-5 against GST (Santa Cruz Biotechnology, Inc.); pAb 
against Rab11 (Invitrogen); mAb 4G10 against phosphotyrosine (Millipore); 
and mAb against     -tubulin (Sigma-Aldrich). Secondary antibodies were 
purchased from Dianova. Alexa Fluor 488  –   and Alexa Fluor 568  –  coupled 
antibodies were purchased from Invitrogen. 
cells and that it is well possible that a considerable fraction of 
plakoglobin molecules is associated with VE-cadherin inde-
pendently of VE-PTP. If this were the case, a large fraction 
of plakoglobin molecules would perhaps not be immediately 
aff  ected by the dissociation of VE-PTP, and the small frac-
tion of potentially dissociating plakoglobin molecules might 
be too small to be detectable in our assays. Nevertheless, re-
gardless of whatever mechanism might be established in the 
future, plakoglobin is a key to understand how VE-PTP af-
fects VE-cadherin. 
  Very recently, it was reported that tyrosine phosphoryla-
tion of VE-cadherin itself is involved in the transmigration of 
leukocytes. Lymphocyte and monocyte binding to endothelial 
cells, as well as cross-linking of ICAM-1, stimulated tyrosine 
phosphorylation of VE-cadherin. In addition, point-mutated 
VE-cadherin with certain tyrosine residues replaced by phe-
nylalanine reduced leukocyte transmigration through endo-
thelial cell layers (  35, 36  ). In this context, it is remarkable that 
induction of VE-PTP in CHO cells still enhanced VE-cad-
herin function despite the absence of all tyrosine residues in 
the cytoplasmic domain of VE-cadherin. This demonstrates 
that yet other substrates besides VE-cadherin exist that mediate 
the enhancing eff  ect of VE-PTP on VE-cadherin function. 
However this does not exclude that in endothelial cells in a 
situation where leukocytes are bound, VE-PTP may contrib-
ute to the dephosphorylation of those VE-cadherin tyrosine 
residues that are relevant for the regulation of VE-cadherin 
function. Indeed, tyrosine phosphorylation of VE-cadherin is 
reduced by VE-PTP in COS-7 and CHO cells (  40  ). In addi-
tion, we found that inhibiting the expression of VE-PTP in 
plakoglobin      /      endothelial cells had a much reduced but still 
signifi  cant inhibitory eff  ect on VE-cadherin function, suggest-
ing that besides plakoglobin there are yet other adherens junc-
tion proteins that could serve as adhesion-aff  ecting substrates, 
including VE-cadherin itself. 
  We were surprised that none of the endothelial adhesion 
receptors that interact with neutrophils and lymphocytes 
(ICAM-1, ICAM-2, E- and P-selectin, PECAM-1, and CD99) 
were essential for leukocyte-induced dissociation of the VE-
PTP  –  VE-cadherin complex. VCAM-1 was not analyzed 
because it is not of importance for neutrophils. Even the 
combined deletion of ICAM-1 and -2 or of P- and E-selectin 
did not abrogate the eff  ect. Soluble factors including oxygen 
radicals are unlikely to be involved, because scavenging of 
oxygen radicals did not inhibit the eff  ect. Several potential 
soluble factors that can be released by neutrophils could be 
excluded, because lymphocytes had the same activity. Further-
more, the dissociation activity could not be transferred to 
fresh endothelial cells with medium taken from endothelial 
cells that had been preincubated with neutrophils. Thus, elu-
cidating the receptor mechanism that transmits the leuko-
cyte-triggered eff  ect on dissociating the VE-PTP –  VE-cadherin 
complex will require more experimental work in the future. 
Interestingly, we found with the VEGF-receptor a leukocyte-
independent mechanism that also triggers the dissociation of 
VE-PTP from VE-cadherin. Thus, diff  erent stimuli that aff  ect 2942 VE-PTP IN LEUKOCYTE DIAPEDESIS   | Nottebaum et al. 
  Alexa Fluor 488  –   or Alexa Fluor 568  –  coupled secondary antibodies. Com-
mercially available antibodies against human VE-PTP could not be used 
because they gave unspecifi  c signals in immunoprecipiatation and immuno-
fl  uorescence. To label early endosomes, subconfl  uent bEnd.3 cells grown on 
chamber slides for 48 h were serum starved for 30 min and then incubated 
for 30 min with 100   μ  g/ml of Texas red  –  conjugated mouse transferrin in in-
ternalization medium (MEM supplemented with 0.8 g/liter NaHCO  3  , 20 
mM Hepes, 1% BSA) at 37  °  C. Fluorescence signals were detected using a 
confocal laser scanning microscope (model TSP2; Leica). 
  Immunoprecipitation and immunoblotting.     For coimmunoprecipita-
tions, cells were lysed in lysis buff  er (20 mM imidazole [pH 6.8], 100 mM 
NaCl, 2 mM CaCl  2  , 1% Triton X-100, 0.04% NaN  3  , and 1  ×   Complete 
EDTA-free protease inhibitor cocktail [Roche]). For detection of phosphoty-
rosine after immunoprecipitation, cells were lysed in lysis buff  er containing 20 
mM Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM CaCl  2  , 1 mM Na  3  VO  4  , 1% 
Triton X-100, 0.04% NaN  3  , and 1  ×   Complete EDTA-free. At no time were 
intact cells exposed to vanadate or peroxyvanadate. For coimmunoprecipita-
tions from mouse lung lysates, lungs were homogenized with an Ultra Turrax 
(IKA-Werke) in three parts of PBS containing 1 mM CaCl  2   and 2  ×   Complete 
EDTA-free protease inhibitor cocktail. Subsequently, one part of 4  ×   lysis buf-
fer (PBS, 4% NP-40, 4 mM dithiothreitol [DTT], 1 mM CaCl  2  ) was added and 
incubated for 4 h at 4  °  C. Lysates were centrifuged at 4  °  C for 30 min or 1 h for 
lung lysates at 20,000   g  , aliquots were set aside for direct blot analysis, and ali-
quots for immunoprecipitation were incubated for 2 h to overnight at 4  °  C with 
protein A  –  sepharose loaded with the respective antibodies. Immunocomplexes 
were washed fi  ve times with lysis buff  er and analyzed by SDS-PAGE. Total cell 
or organ lysates (3   ×   10  5   cells/lane, 50   μ  g of protein/lane) or immunoprecipi-
tated material were separated by electrophoresis on 6% (immunoprecipitation) 
or 8% (direct immunoblots of cell lysates) SDS-PAGE and transferred to nitro-
cellulose (Schleicher   &   Schuell) by wet blotting. Blots were analyzed as previ-
ously described (  51  ). For detection of phosphotyrosine, milk powder in the 
blocking buff  er was replaced by 2% BSA, and 200   μ  M Na  3  VO  4   was added. 
  VE-PTP substrate trapping.     For substrate trapping pull-down experi-
ments, three 15-cm plates of confl  uent L929 cells were pretreated with 10 
  μ  M of proteasome inhibitor for 2  –  3 h (to increase plakoglobin expression 
levels) and 1 mM pervanadate for 30 min and lysed (20 mM Tris/HCl [pH 
7.5], 100 mM NaCl, 1 mM EDTA, 1% Triton X-100, 10% glycerine, 5 mM 
iodoacetic acid [IAA], 1  ×   Complete EDTA-free protease inhibitor cocktail 
[Roche]) for 30 min at 4  °  C. Subsequently, 10 mM DTT was added to inac-
tivate IAA. After centrifugation at 14,000   g   for 30 min at 4  °  C, cleared lysates 
were incubated overnight with 7   μ  g GST, GST  –  VE-PTP, or GST  –  VE-PTP 
C/S D/A bound to glutathione-sepharose, as previously described (  42  ). Beads 
were washed four times with 5 ml and fi  ve times with 1 ml of lysis buff  er and 
were analyzed by SDS-PAGE and immunoblotting. 
  RNA interference.     For RNA interference of VE-PTP and hPTP-     
expression, the following siRNAs were used: VE-PTP-34, 5    -CCU-
CACUGAGGGUAACAGU-3     (targeting VE-PTP); and siPTP-82, 5    -GA-
CAGUAUGAGGUGGAAGU-3     (targeting hPTP-    ; Ambion). For negative 
controls, an siRNA was used that does not target any known mammalian 
gene (5    -UUCUCCGAACGUGUCACGU-3    ; QIAGEN). Routinely, 10  6   
bEnd.5 cells or HUVECs were transfected with 3 or 4   μ  g siRNA, respectively, 
using nucleofection (Amaxa Biosystems) according to manufacturer  ’  s instruc-
tions. For detection of tyrosine phosphorylation, single nucleofection reactions 
of bEnd.5 cells and HUVECs were scaled up fi  ve- and threefold, respectively. 
  Permeability assay.     To determine paracellular permeability, 1.25   ×   10  5   
endothelioma cells were seeded per 6.5-mm-diameter Transwell fi  lters 
(Costar 3413; Corning) with a 0.4-  μ  m pore size, coated with 50   μ  g/ml 
laminin. After nucleofection, bEnd.5 cells were cultured for 24 h before 
the assay. Permeability was analyzed with 0.25 mg/ml FITC-dextran (250 
kD; Sigma Aldrich), and diff  usion was allowed for 30 min at 37  °  C and 10% 
CO  2  . Fluorescence in the lower chamber was measured with a fl  uorimeter 
  DNA constructs.     Based on the mouse cDNA of VE-cadherin (  52  ) inserted 
via EcoRI/XbaI sites into pcDNA3, truncation mutants VE-cadherin     42 or 
    83 were generated by PCR using the following primers: the sense primer 
T7 (5    -TAATACGACTCACTATAGGG-3    ) and the antisense primers 
VECP33 (5    -CGTCTAGACTAGGACTCTGCGATGGACTCTGCG-3    ) 
for VE-cadherin     42 and VECP32 (5    -CGTCTAGACTATCCGTG-
CAGTCCAGGCG-3    ) for VE-cadherin     83. VE-cadherin YallF mutant 
was generated by using the QuikChange Site-Directed Mutagenesis Kit 
(Agilent Technologies). GST  –  VE-PTP and the trapping mutant GST  –  VE-
PTP C/S were previously described (  37  ). The D/A mutation was introduced 
into GST  –  VE-PTP C/S by PCR using the following primers: antisense 
(5    -CTCTGGGACCCCATGGGCTGGCCACACCGTGTAG-3    ) and 
sense (5    -CTACACGGTGTGGCCAGCCCATGGGGTCCCAGAG-3    ). 
GST, GST  –  VE-PTP, and GST  –  VE-PTP C/S D/A fusion proteins were 
expressed in   Escherichia coli   (strain BL21). 
  Cell culture.     The following cells were propagated as described: CHO cells 
(  40  ), CHO cells expressing mouse VE-cadherin (  21  ), bEnd.3 cells (  53  ), 
bEnd.5 cells (  54  ) and HUVECs (  55  ), E- and P-selectin      /      endothelioma 
bEndE/P.5 cells (  56  ), ICAM-1 and -2      /      endothelioma bEndI1/2.1 cells 
(  57  ), PECAM-1      /      endothelioma luEnd.PECAM-1.9 cells (  58  ), and L929 
fi  broblasts (Sigma-Aldrich). OTII-Ova T cells expressing      and      chains of 
a TCR specifi  c for peptide 323  –  339 of ovalbumin in the context of I-A b 
were isolated from OTII mice (The Jackson Laboratory). Embryonic endo-
thelioma cells were cultured in bEnd.5 growth medium. For stimulation 
with VEGF, bEnd.5 cells were grown to confl  uence in DMEM/10%FCS, 
washed twice with MCDB 131 medium (Invitrogen) containing 1% BSA, 
and stimulated with 100 ng/ml of recombinant VEGF165 (PeproTech) in 
MCDB 131 medium with 1% BSA for the time periods indicated in the fi  g-
ures (from 5 min to 3 h). Cells were analyzed by immunoprecipitation. 
  Generation of stable cell lines.     CHO-    A36#25 cells (expressing VE-PTP 
upon mifepristone induction) were generated by cotransfecting pSwitch plas-
mid (hygromycin resistance; Invitrogen) with the expression plasmid pGene/
V5-HisA containing the mouse VE-PTP fl   cDNA. Co-transfecting CHO-
    A36#25 cells with the expression plasmid pCDNA3 (neomycin resistance; 
Invitrogen) containing mouse VE-cadherin YallF cDNA together with the 
expression plasmid pEF6 (blasticidin resistance; Invitrogen) containing the 
mouse VEGFR-2 cDNA gave rise to CHO-YallF. CHO     42 and     83 were 
generated by cotransfecting CHO-    A36#25 with the expression plasmid 
pCDNA3 containing mouse VE-cadherin     42 or     83 cDNA together with 
expression plasmid pEF6 containing the mouse VEGFR-2 cDNA. Expres-
sion of transfected genes was assessed by FACS analysis. Expression of 
VE-PTP was induced with mifepristone for 10 h at 37  °  C. Mifepristone 
is a synthetic steroid compound driving an inducible expression system 
(GeneSwitch; Invitrogen). 
  Generation of plakoglobin      /       and     -catenin      /       endothelioma cell 
lines.     Plakoglobin      /      and     -catenin  fl  /      endothelioma cells were generated 
by polyoma middle T immortalization of cell cultures established from plako-
globin-defi  cient E9.5 mouse embryos, or from primary brain endothelial cell 
cultures established from newborn     -catenin  fl  /      mice, respectively, according 
to previously published methods (  54, 59  ). Gene-disrupted mice were pro-
vided by R. Kemler (Max-Planck-Institute of Immunobiology, Freiburg, 
Germany). All mice were housed under pathogen-free conditions at the 
Max-Planck-Institute  ’  s Animal Facility, and were used in accordance with 
guidelines and under permission of the Regierungspr  ä  sidium M  ü  nster. Dele-
tion of the fl  oxed     -catenin allele was accomplished by infection with Cre-
expressing adenovirus obtained from U. M  ü  ller (Friedrich Miescher Institute 
for Biomedical Research, Basel, Switzerland). 
  Immunofl  uorescence staining.     For detection of VE-PTP in endotheli-
oma of increasing confl  uency, 10  4   bEnd.3 endothelioma cells were seeded 
on laminin-coated Transwell fi  lters and stained 2, 5, and 8 d after seeding. 
Primary antibodies were detected with Cy2- and Cy3-coupled or with JEM VOL. 205, November 24, 2008 
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  Adhesion assay.     For adhesion of bEnd.5, plakoglobin      /     , and     -catenin      /      
cells to immobilized VE-cadherin  –  Fc, 96-well plates were coated with 20   μ  g/
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MgCl  2   (PBS-MC) overnight at 4  °  C, followed by blocking with 3% BSA in 
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at 37  °  C. After washing with PBS-MC until background binding to E-selectin  –
  Fc was minimal, adhering cells were fi  xed for 20 min with cold methanol 
(    20  °  C), rehydrated in PBS-MC, and counted by fl  uorescence microscopy. 
  Transmigration assay.     Transendothelial migration of PMNs across bEnd.5 
monolayers was performed essentially as previously described (  14  ), except that 
10  6   PMNs were added per Transwell fi  lter, TNF-     activation was omitted, 
and transmigration was allowed for 15 min. Transmigration across HUVEC 
monolayers was analyzed by adding 4   ×   10  5   human neutrophils for 20 min to 
TNF-      –  activated HUVECs grown on gelatin-coated coverslips, followed by 
fi   xation with 2% glutaraldehyde. Transmigrated cells were identifi  ed  and 
counted by phase-contrast microscopy. 
  Adhesion of leukocytes to endothelium.     Highly confl  uent bEnd.5 cells 
in a 90-mm dish either stimulated for 6 h with 5 nM TNF-     or left unstimu-
lated were incubated for 5 min with either 3   ×   10  7   PMNs (freshly isolated 
from mouse bone marrow) or the same number of antigen-stimulated T cells 
(both previously described in reference   14  ) in 2.5 ml of growth medium at 
37  °  C and 10% CO  2  . Adhering cells were removed by washing three to fi  ve 
times with prewarmed PBS. Of note, in contrast to human leukocytes added 
to HUVECs, mouse leukocytes added to mouse endothelioma could be re-
moved quantitatively with PBS. In some experiments, lymphocytes were in-
cubated for 30 min and then removed. Subsequently, endothelial cells were 
lysed and analyzed by immunoprecipitation. 
  Aggregation assays.     Aggregation assays with transfected CHO cells were 
essentially performed as previously described (  13, 14  ), except that cells were 
harvested with 0.05% trypsin in HBSS supplemented with 25 mM Hepes, 
pH 7.3, (HHBSS) in the presence of 5 mM CaCl  2   and 2 mM MgCl  2  . Tryp-
sin was stopped with DMEM containing 10% FCS and 0.05% soybean tryp-
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  Statistical analysis.     Statistical signifi  cance was analyzed using the Student  ’  s 
  t   test for independent samples. p-values are indicated by asterisks: *, P   <   0.05; 
**, P   <   0.01; and ***, P   <   0.001. Results are shown as means   ±   SEM. 
  Online supplemental material.     Fig. S1 shows that distribution and ex-
pression of various endothelial cell contact proteins are unaff  ected by VE-
PTP or hPTP     silencing (24 h after transfection) in mouse endothelioma or 
HUVECs, respectively. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20080406/DC1. 
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